---
granola_id: eab4dbce-c688-4530-b119-140266567639
title: "Virtue / Prudentia"
type: note
created: 2025-09-02T19:05:52.352Z
updated: 2025-09-30T14:11:39.560Z
attendees:
  - sd@virtuevc.com
  - sm@prudentiasciences.com
---
### Series A Fundraising Progress

- GV showing strong interest after 2-hour deep dive session
	- Anthony surprised by execution speed, asked if they want to lead
	- Considering taking the full round before opening to others
	- GV retreat on Sept 15th for final decision
- Target raise: $25-30M (wonâ€™t exceed 20% dilution)
- Strong pipeline creating urgency among investors
	- Mo and NEA interested
	- Lightspeed in mix (concerns about board member Renton)
	- Copper Tea very interested after Shelby call
	- Sequoia (Doug + Constantine/Alfred) visiting Boston
	- Bain Capital (Ricky) meeting in person
	- Transformation Capital and McGason Ventures ($5M check)
- 7-8 investors visiting Boston between Sept 11-30
- Signal Fire likely to be skipped from process

### Commercial Traction & Pipeline

- Current contracting: 9 enterprise deals totaling $6.2M first-year revenue
	- Average deal size: $950K for mid-size pharma
	- Large pharma deals: $2.2-2.5M (J&J, Roche)
- Total pipeline: 30 deals
	- Diligence module
	- Valuation module
	- Competitive Intelligence module ($1M additional per customer)
- Key customers in late-stage contracting:
	- CSL, Stellas, Merida (design partners for CI module)
	- BMS, Endo, GSK, Takeda anticipated at $1M each
	- Royalty groups: Zoma (in contracting), Omar, LT (early stage)
- All contracts include auto-renewal, 3-year MSA terms
- J&J LinkedIn post catalyst: driving 4 inbounds per week

### Product Evolution & Market Expansion

- New features launched:
	- Prospect tool (deck analysis without ChatGPT)
	- Full data room integration within platform
	- Executive summary creation for biotechs
- Marketplace development accelerating
	- CSL requesting access to all biotechs on platform
	- Two biotechs running processes with investors via platform
	- Fidelity (Mona Vernon) supporting marketplace setup
- China expansion planned for Series A
	- Hired GB alum to map entire China market
	- Biotech offering launching in Mandarin
- Reference customers prepared for investor due diligence

Chat with meeting transcript: https://notes.granola.ai/d/eab4dbce-c688-4530-b119-140266567639
